This report summarises the discussions and conclusions of the meeting, but does not reflect the institutional positions of the co-hosting parties.
7TH BRANDENBURG FORUM ON DRUGS AND DEVELOPMENT POLICIES “TOWARDS 2024 – A KEY MILESTONE IN GLOBAL DRUG POLICY”
The 7th Brandenburg Forum on Drugs and Development Policies took place from 16th to 18th November 2022, at the Schloss Lübbenau in Brandenburg, Germany. The Forum was organised by the Global Partnership on Drug Policies and Development (GPDPD) – commissioned by the German Federal Ministry for Economic Cooperation and Development (BMZ) and implemented under political patronage of the Commissioner of the Federal Government for Drug and Addiction Policy. The meeting was co-hosted by the Government of the Netherlands, the Norwegian Ministry of Health and Care Services, the Transnational Institute (TNI), and the International Drug Policy Consortium (IDPC). The Forum was attended by 53 participants from around the world – including government representatives from Albania, Belgium, Colombia, Czechia, Finland, Germany, Ghana, Jamaica, Kenya, Malaysia, Mexico, the Netherlands, Norway, Peru, Portugal, Spain, Switzerland, Thailand, the United Kingdom, Uruguay, and the USA. Also in attendance were officials from the European Union, the Office of the United Nations High Commissioner for Human Rights (OHCHR), the United Nations Development Programme (UNDP), the United Nations Office on Drugs and Crime (UNODC) and the World Health Organization (WHO), as well as leading civil society organisations. In order to promote open dialogue, discussions were conducted under the ‘Chatham House Rule’ whereby contents can be shared but neither the identity nor the affiliation of any participants may be revealed.
- Global Partnership on Drug Policies and Development (GPDPD)
- Transnational Institute (TNI)
- International Drug Policy Consortium (IDPC)
- German Federal Ministry for Economic Cooperation and Development (BMZ)
- Germany's Commissioner of the Federal Government for Drug and Addiction Policy
- Government of the Netherlands
- Norwegian Ministry of Health and Care Services